Theratechnologies Inc.
TH.TO
TSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.61% | 8.37% | 25.46% | -18.39% | 9.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.61% | 8.37% | 25.46% | -18.39% | 9.48% |
| Cost of Revenue | 20.33% | -8.98% | -7.37% | 12.59% | -14.27% |
| Gross Profit | 2.83% | 13.79% | 38.21% | -27.95% | 18.53% |
| SG&A Expenses | 44.19% | -11.34% | -7.24% | -16.06% | 189.55% |
| Depreciation & Amortization | -42.70% | -- | -- | -- | -72.72% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.97% | -21.22% | -26.53% | -26.95% | -30.63% |
| Operating Income | -80.16% | 11,405.56% | 141.39% | 58.46% | 181.17% |
| Income Before Tax | -156.60% | 720.48% | 111.18% | 57.76% | 65.55% |
| Income Tax Expenses | 1,298.63% | 500.00% | -6.35% | 14.58% | -48.95% |
| Earnings from Continuing Operations | -186.86% | 514.34% | 109.86% | 57.09% | 65.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -186.86% | 514.34% | 109.86% | 57.09% | 65.25% |
| EBIT | -80.16% | 11,405.56% | 141.39% | 58.46% | 181.17% |
| EBITDA | -74.13% | 688.80% | 162.95% | 60.33% | 205.19% |
| EPS Basic | -90.14% | 303.25% | 104.83% | 78.96% | 74.61% |
| Normalized Basic EPS | -478.79% | 404.38% | 105.48% | 72.61% | 101.62% |
| EPS Diluted | -90.14% | 294.81% | 104.83% | 78.96% | 74.61% |
| Normalized Diluted EPS | -478.79% | 404.38% | 105.48% | 72.61% | 101.62% |
| Average Basic Shares Outstanding | 50.84% | 103.96% | 103.96% | 103.96% | 36.87% |
| Average Diluted Shares Outstanding | 50.84% | 104.00% | 103.99% | 103.96% | 36.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
